Researchers continue to excited about Retatrutide , a innovative dual compound showing remarkable results in initial trials for size reduction . It acts by targeting both hormones : GLP-1 and GIP, that , when engaged , help control appetite and boost metabolism . Initial observations suggest substantial body reduction and possible improvements for